Global Gangrene Market is Expected to Grow with CAGR of 8.3% During the Period 2022 to 2030

Pune, India, December, 2022 /MRFR Press Release/- Market Research Future published a half-cooked research report on global Gangrene market. 

Market Highlights

Global Gangrene Market Is Expected to reach USD 2926.6 million at CAGR of 8.3% During the Period 2022 to 2030. The Global Gangrene Market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. Increasing demand for advanced wound therapies is boosting the revenues per year.

Global Gangrene Market:

Gangrene is a condition in which living tissues begins to decay and die because of blood oxygen to an area is blocked or due to harmful bacteria invades the body's tissues after entering through a wound or sore. In the United States, approximately 50% of moist gangrene cases are the result of a severe traumatic injury including car and industrial accidents, crush injuries, and gunshot wounds are the most common traumatic causes. Continuous increasing need for advanced and non-invasive therapies with improved outcomes has boosted the growth of the market.

Key Players:

MediPurpose Private Limited (US), Baril Corporation (US), McKesson Corporation, Cardinal Health (Dublin), Advanced Tissue (US), TRIAGE MEDITECH PVT. LTD. (India), Integra LifeSciences Corporation (US), Covalon Technologies Ltd. (Canada), Advanced Medical Solutions Group plc (UK) and others.Explore In-depth Details: Gangrene Market Research Report

Market Research Analysis:

In recent years, due to increasing demand for the advanced wound treatment techniques has helped in driving the growth of the market. In the coming years, it is expected that the Global Gangrene Market will advance with higher growth rate as compared to previous years.